Dong-A PharmTech announces start of Phase II trials for Udenafil in Mexico
In its regulatory filing, the company said that the Phase II study is designed to evaluate the safety and e...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
